40 years on, breast cancer drug shows potential to repair myelin

A drug that is a well-established treatment for breast cancer now looks set to be a new remyelination therapy for MS. Tamoxifen has been used to treat breast cancer since the early 1970s, but University of Cambridge, UK, researchers have found some previously unknown benefits of the treatment. Dr Mark Kotter, who led the project, … Continue reading 40 years on, breast cancer drug shows potential to repair myelin

Remyelination Studies Abound, But How About a Workable Therapy?

Remyelination at the moment is the buzzword to beat all buzzwords in the world of research into, and treatment for, the vicious disease that is multiple sclerosis. Now, as you are reading this, you must have some knowledge of MS and are sure to know about the link between the loss of the myelin sheath and … Continue reading Remyelination Studies Abound, But How About a Workable Therapy?

New multiple sclerosis treatment to repair myelin is at phase 2 trial stage of development

Anti-LINGO-1 (also known as BIIB033) is a new MS treatment being development by the pharmaceutical company Biogen. It is currently being tested in people with optic neuritis, relapsing remitting MS and secondary progressive MS in phase 2 clinical trials. LINGO is a protein found in nerve cells and myelin-making cells called oligodendrocytes. Blocking the activity … Continue reading New multiple sclerosis treatment to repair myelin is at phase 2 trial stage of development